292 related articles for article (PubMed ID: 35883495)
21. Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
Men C; Chai H; Song X; Li Y; Du H; Ren Q
J Gynecol Oncol; 2017 Nov; 28(6):e83. PubMed ID: 29027401
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
[TBL] [Abstract][Full Text] [Related]
23. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide DNA methylation analysis in obese women predicts an epigenetic signature for future endometrial cancer.
Nagashima M; Miwa N; Hirasawa H; Katagiri Y; Takamatsu K; Morita M
Sci Rep; 2019 Apr; 9(1):6469. PubMed ID: 31015518
[TBL] [Abstract][Full Text] [Related]
26. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
Ni J; Tian W; Liang S; Wang H; Ren Y
Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
[No Abstract] [Full Text] [Related]
27. DNA Methylation Machinery in the Endometrium and Endometrial Cancer.
Caplakova V; Babusikova E; Blahovcova E; Balharek T; Zelieskova M; Hatok J
Anticancer Res; 2016 Sep; 36(9):4407-20. PubMed ID: 27630276
[TBL] [Abstract][Full Text] [Related]
28. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
29. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
30. Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.
Banno K; Nogami Y; Kisu I; Yanokura M; Umene K; Masuda K; Kobayashi Y; Yamagami W; Susumu N; Aoki D
Int J Mol Sci; 2013 Jun; 14(6):12123-37. PubMed ID: 23743825
[TBL] [Abstract][Full Text] [Related]
31. HDAC as a therapeutic target for treatment of endometrial cancers.
Ren J; Zhang J; Cai H; Li Y; Zhang Y; Zhang X; Zhao D; Li Z; Ma H; Wang J; Gao YE; Xiao L; Liu R; Qian J; Liu Y; Wei H; Li J
Curr Pharm Des; 2014; 20(11):1847-56. PubMed ID: 23888962
[TBL] [Abstract][Full Text] [Related]
32. Non-Coding RNAs as Prognostic Markers for Endometrial Cancer.
Piergentili R; Zaami S; Cavaliere AF; Signore F; Scambia G; Mattei A; Marinelli E; Gulia C; Perelli F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808791
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic changes as prognostic predictors in endometrial carcinomas.
Farkas SA; Sorbe BG; Nilsson TK
Epigenetics; 2017 Jan; 12(1):19-26. PubMed ID: 27874289
[TBL] [Abstract][Full Text] [Related]
34. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
35. Application of DNA methylation biomarkers for endometrial cancer management.
Jiang SW; Li J; Podratz K; Dowdy S
Expert Rev Mol Diagn; 2008 Sep; 8(5):607-16. PubMed ID: 18785809
[TBL] [Abstract][Full Text] [Related]
36. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
Dewdney SB; Rimel BJ; Thaker PH; Thompson DM; Schmidt A; Huettner P; Mutch DG; Gao F; Goodfellow PJ
Clin Cancer Res; 2011 Apr; 17(8):2120-9. PubMed ID: 21372219
[TBL] [Abstract][Full Text] [Related]
38. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
[TBL] [Abstract][Full Text] [Related]
39. [Pseudogene PTENP1 5'-region methylation in endometrial cancer and hyperplasias].
Kovalenko TF; Sorokina AV; Ozolinia LA; Patrushev LI
Bioorg Khim; 2013; 39(4):445-53. PubMed ID: 24707726
[TBL] [Abstract][Full Text] [Related]
40. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
